StockData
Curanex Pharmaceuticals Inc logo

Curanex Pharmaceuticals Inc (CURX) stock

CURXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$4.70+0.07 (+1.40%)

Close on Nov 17, 2026Market cap $7.37MP/E –Yield –

Curanex Pharmaceuticals EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Curanex Pharmaceuticals

Curanex Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Curanex Pharmaceuticals figures

See a number that looks wrong?